FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1860436001> ?p ?o ?g. }

• W1860436001 endingPage "7" @default.
• W1860436001 startingPage "2851" @default.
• W1860436001 abstract "To evaluate weekly induction chemotherapy followed by weekly concomitant chemoradiotherapy in a multicentre phase II study of patients with unresectable stage III non-small cell lung cancer (NSCLC; stage wet IIIB excluded).Eligible patients received three weekly cycles of paclitaxel 100 mg/m2 and carboplatin AUC2 followed by six weekly cycles of paclitaxel 60 mg/m2 and carboplatin AUC2 in combination with thoracic radiotherapy (2 Gy per fraction and day to a total dose of 60 Gy).Sixty-four patients (40 males and 24 females) with a median age of 63 years (range, 43-79 years) entered the study. T and N stage were distributed as follows: T1 2 patients (3.2%), T2 10 patients (15.6%), T3 15 patients (23.4%), T4 37 patients (57.8%); N0 10 patients (15.6%), N1 1 patient (1.6%), N2 26 patients (40.6%), N3 26 patients (40.6%), and N missing 1 patient (1.6%). Seven patients (10.9%) suffered from grade 3/4 oesophagitis. Grade 1/2 oesophagitis occurred in 36 patients (56.3%) and pneumonitis grade 1/2 occurred in 10 patients (15.6%). Sixty-three patients were evaluated on an intent-to-treat basis. The overall response rate was 74.6%. The median time to progression was 247 days and median overall survival was 461 days. According to subgroup analyses, no statistically significant differences were noted according to gender, age (<65 vs. > or =65 years), performance status, histology, or study centre.Induction chemotherapy followed by concurrent chemoradiotherapy with weekly cycles of paclitaxel and carboplatin is feasible and generates moderate toxicity. Efficacy is comparable to other recently published regimens. However, prognosis remains, in general, poor for this group of patients and further work to develop better therapy is required." @default.
• W1860436001 created "2016-06-24" @default.
• W1860436001 creator A5005280125 @default.
• W1860436001 creator A5013212279 @default.
• W1860436001 creator A5014475951 @default.
• W1860436001 creator A5027517528 @default.
• W1860436001 creator A5034078360 @default.
• W1860436001 creator A5034925806 @default.
• W1860436001 creator A5035911657 @default.
• W1860436001 creator A5037079479 @default.
• W1860436001 creator A5045117644 @default.
• W1860436001 creator A5059703200 @default.
• W1860436001 creator A5063054956 @default.
• W1860436001 creator A5064527130 @default.
• W1860436001 creator A5071440587 @default.
• W1860436001 creator A5078333072 @default.
• W1860436001 creator A5088103868 @default.
• W1860436001 creator A5089745967 @default.
• W1860436001 date "2008-11-27" @default.
• W1860436001 modified "2023-10-16" @default.
• W1860436001 title "Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer." @default.
• W1860436001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19031924" @default.
• W1860436001 hasPublicationYear "2008" @default.
• W1860436001 type Work @default.
• W1860436001 sameAs 1860436001 @default.
• W1860436001 citedByCount "4" @default.
• W1860436001 countsByYear W18604360012014 @default.
• W1860436001 countsByYear W18604360012017 @default.
• W1860436001 crossrefType "journal-article" @default.
• W1860436001 hasAuthorship W1860436001A5005280125 @default.
• W1860436001 hasAuthorship W1860436001A5013212279 @default.
• W1860436001 hasAuthorship W1860436001A5014475951 @default.
• W1860436001 hasAuthorship W1860436001A5027517528 @default.
• W1860436001 hasAuthorship W1860436001A5034078360 @default.
• W1860436001 hasAuthorship W1860436001A5034925806 @default.
• W1860436001 hasAuthorship W1860436001A5035911657 @default.
• W1860436001 hasAuthorship W1860436001A5037079479 @default.
• W1860436001 hasAuthorship W1860436001A5045117644 @default.
• W1860436001 hasAuthorship W1860436001A5059703200 @default.
• W1860436001 hasAuthorship W1860436001A5063054956 @default.
• W1860436001 hasAuthorship W1860436001A5064527130 @default.
• W1860436001 hasAuthorship W1860436001A5071440587 @default.
• W1860436001 hasAuthorship W1860436001A5078333072 @default.
• W1860436001 hasAuthorship W1860436001A5088103868 @default.
• W1860436001 hasAuthorship W1860436001A5089745967 @default.
• W1860436001 hasConcept C126322002 @default.
• W1860436001 hasConcept C141071460 @default.
• W1860436001 hasConcept C146357865 @default.
• W1860436001 hasConcept C151730666 @default.
• W1860436001 hasConcept C2776256026 @default.
• W1860436001 hasConcept C2776694085 @default.
• W1860436001 hasConcept C2776907518 @default.
• W1860436001 hasConcept C2777292972 @default.
• W1860436001 hasConcept C2778239845 @default.
• W1860436001 hasConcept C2778424827 @default.
• W1860436001 hasConcept C2779384505 @default.
• W1860436001 hasConcept C2781451048 @default.
• W1860436001 hasConcept C509974204 @default.
• W1860436001 hasConcept C71924100 @default.
• W1860436001 hasConcept C86803240 @default.
• W1860436001 hasConcept C90924648 @default.
• W1860436001 hasConceptScore W1860436001C126322002 @default.
• W1860436001 hasConceptScore W1860436001C141071460 @default.
• W1860436001 hasConceptScore W1860436001C146357865 @default.
• W1860436001 hasConceptScore W1860436001C151730666 @default.
• W1860436001 hasConceptScore W1860436001C2776256026 @default.
• W1860436001 hasConceptScore W1860436001C2776694085 @default.
• W1860436001 hasConceptScore W1860436001C2776907518 @default.
• W1860436001 hasConceptScore W1860436001C2777292972 @default.
• W1860436001 hasConceptScore W1860436001C2778239845 @default.
• W1860436001 hasConceptScore W1860436001C2778424827 @default.
• W1860436001 hasConceptScore W1860436001C2779384505 @default.
• W1860436001 hasConceptScore W1860436001C2781451048 @default.
• W1860436001 hasConceptScore W1860436001C509974204 @default.
• W1860436001 hasConceptScore W1860436001C71924100 @default.
• W1860436001 hasConceptScore W1860436001C86803240 @default.
• W1860436001 hasConceptScore W1860436001C90924648 @default.
• W1860436001 hasIssue "5B" @default.
• W1860436001 hasLocation W18604360011 @default.
• W1860436001 hasOpenAccess W1860436001 @default.
• W1860436001 hasPrimaryLocation W18604360011 @default.
• W1860436001 hasRelatedWork W1967576136 @default.
• W1860436001 hasRelatedWork W2006804882 @default.
• W1860436001 hasRelatedWork W2009608310 @default.
• W1860436001 hasRelatedWork W2018892965 @default.
• W1860436001 hasRelatedWork W2022907323 @default.
• W1860436001 hasRelatedWork W2029751060 @default.
• W1860436001 hasRelatedWork W2031646868 @default.
• W1860436001 hasRelatedWork W2043119894 @default.
• W1860436001 hasRelatedWork W2093851535 @default.
• W1860436001 hasRelatedWork W2094886734 @default.
• W1860436001 hasRelatedWork W2128769524 @default.
• W1860436001 hasRelatedWork W2152520755 @default.
• W1860436001 hasRelatedWork W2155863042 @default.
• W1860436001 hasRelatedWork W2172202839 @default.
• W1860436001 hasRelatedWork W2404500006 @default.
• W1860436001 hasRelatedWork W2408969459 @default.
• W1860436001 hasRelatedWork W2418815002 @default.

• next